Berkland among five WashU faculty receiving grants for innovative cancer research
Berkland is a Professor in the Department of Biomedical Engineering
The American Cancer Society (ACS) and venture capital firm Yosemite have selected five Washington University in St. Louis faculty to receive the inaugural ACS-Yosemite research grants. The new funding opportunity supports 20 creative scientists around the country who are advancing immuno-oncology, cell therapy or artificial intelligence approaches to preventing, diagnosing or treating cancer. Each scholar receives $330,000.
The WashU recipients are:
Cory Berkland, the Mark and Becky Ruhmann Levin Professor in the McKelvey School of Engineering and a professor of chemistry in Arts & Sciences, will focus on a new cancer immunotherapy that seeks to recruit immune cells to tumor tissue and works synergistically with checkpoint inhibitors, which “release the brakes” of the immune system. He will further develop an engineered variant of the cytokine GM-CSF that is designed to “stick” in tumor tissue to alleviate immune-related adverse events and strengthen immune activity.
Read the full story here.
Click on the topics below for more stories in those areas
Back to NewsFaculty in this story
